Caution in using second generation tyrosine kinase inhibitor, especially for first line therapy of chronic myeloid leukemia. Issue 8 (9th June 2022)

Record Type:: Journal Article
Title:: Caution in using second generation tyrosine kinase inhibitor, especially for first line therapy of chronic myeloid leukemia. Issue 8 (9th June 2022)
Main Title:: Caution in using second generation tyrosine kinase inhibitor, especially for first line therapy of chronic myeloid leukemia
Authors:: Gambacorti‐Passerini, Carlo
Nicolini, Franck Emmanuel
Larson, Richard A.
Aroldi, Andrea
Fontana, Diletta
Piazza, Rocco
le Coutre, Philipp
Antolini, Laura
Assouline, Sarit
Abstract:
Is Part Of:: American journal of hematology. Volume 97:Issue 8(2022)
Journal:: American journal of hematology
Issue:: Volume 97:Issue 8(2022)
Issue Display:: Volume 97, Issue 8 (2022)
Year:: 2022
Volume:: 97
Issue:: 8
Issue Sort Value:: 2022-0097-0008-0000
Page Start:: E296
Page End:: E298
Publication Date:: 2022-06-09
Subjects:: Hematology -- Periodicals
616.15
Journal URLs:: http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)1096-8652 ↗
http://onlinelibrary.wiley.com/ ↗
DOI:: 10.1002/ajh.26618 ↗
Languages:: English
ISSNs:: 0361-8609
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - 0824.800000
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store
Ingest File:: 22383.xml